**SNDY.0010 Doctor's filing uncovered. This stock is ready to go through the roof. Ran to .02+ last year within DAYS! Breast Cancer is a HUGE Billion Dollar market. Invest for a worthy cause with no pump intended. See the filing below for factual evidence of the doctors investment in SNDY!
Here is the filing of the doctor's investment in SNDY-.......
Statement of Beneficial Ownership (SC 13D)
Date : 07/07/2011 @ 11:45AM
Source : Edgar (US Regulatory)
Stock : Solos Endoscopy (PC) (SNDY)
Quote : 0.001 0.0002 (25.00%) @ 5:00PM
- Statement of Beneficial Ownership (SC 13D)
PrintAlert
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __)
TITLE OF CLASS OF SECURITES
Solos Endoscopy
CUSIP NUMBER:
834371403
NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND
COMMUNICATIONS
Richard Tuch, M.D.
1800 Fairburn Avenue, Suite 206
Los Angeles, CA 90025
(310) 474-1960
DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT
June 28, 2011
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), (f) or (g), check the following box.
[ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 (b) for other
parties to whom copies are to be sent.
The remainder of this cover page shall be filled out for a reporting persons
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange
Act of 1934 (Act) or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
1. NAMES OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Richard Tuch, M.D.
------------------------------------------------------------------------------
-------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
------------------------------------------------------------------------------
-------------------------------------------------
3. SEC USE ONLY
------------------------------------------------------------------------------
-------------------------------------------------
4. SOURCE OF FUNDS*
00
------------------------------------------------------------------------------
-------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) [ ]
-------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
California
------------------------------------------------------------------------------
-------------------------------------------------
7. SOLE VOTING POWER
5,500,000
------------------------------------------------------
-------------------------------------
NUMBER OF 8. SHARED VOTING POWER
SHARES BENEFICIALLY -0-
OWNED BY EACH ------------------------------------------------------
-------------------------------------
REPORTING PERSON 9. SOLE DISPOSITIVE POWER
WITH 5,500,000
------------------------------------------------------
-------------------------------------
10. SHARED DISPOSITIVE POWER
-0-
------------------------------------------------------
-------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,500,000
------------------------------------------------------------------------------
-------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [
]
------------------------------------------------------------------------------
-------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.5% of Common Stock
------------------------------------------------------------------------------
-------------------------------------------------
14. TYPE OF REPORTING PERSON*
EP
------------------------------------------------------------------------------
-------------------------------------------------
SCHEDULE 13D
ITEM 1. SECURITY AND ISSUER
Richard Tuch, M.D.
ITEM 2. IDENTITY AND BACKGROUND
(a) Name
Richard Tuch, M.D., A Professional Corporation, Profit Sharing
Plan (401K)
(b) Business Address
1800 Fairburn Ave., Ste. 206
Los Angeles, CA 90025
(c) Present Principal Occupation
Richard Tuch, M.D. is a physician in private practice in Los
Angeles, California and a private investor.
(d) During the last five years, Dr. Tuch has not been convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) During the last five years, Dr. Tuch has not been a party to a
civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which he was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such
laws.
(f) Citizenship
United States of America
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The source of the funds is from Dr. Tuchs Profit Sharing Pension Plan (401K).
No funds were borrowed.
ITEM 4. PURPOSE OF TRANSACTION
Richard Tuch has acquired all of the 5,500,000 shares for investment purposes
and currently has no plans or proposals that relate to or would result in:
(a) The acquisition by any person or additional securities of the
Issuer or the disposition of securities of the Issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Issuer or any of its
subsidiaries;
(c) A sale or transfer of a material amount of assets of Issuer or any
of its subsidiaries;
(d) Any change in the present board of directors or management of
Issuer, including any plans or proposals to change the number or
term of directors or to fill any existing vacancies on the board;
(e) Any material change in the present capitalization or dividend
policy of Issuer;
(f) Any other material change in Issuer business or corporate
structure;
(g) Changes in Issuers charter, bylaws or instruments corresponding
thereto or other actions which may impede the acquisition of
control of Issuer by any person;
(h) Causing a class of securities of Issuer to be delisted from a
national securities exchange or to cease to be authorized to be
quoted in an inter-dealer quotation system of a registered
national securities association;
(i) A class of equity securities of Issuer becoming eligible for
termination of registration pursuant to Section 12(g) (4) of the
Act;
(j) Any action similar to any of those enumerated above.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Aggregate Number and Percentage of Securities
According to the most recently available information, there are
64,957,710 shares of Issuer common stock outstanding. Richard
Tuch is the record owner of 5,500,000 shares of Issuer common
stock and Dr. Tuch beneficially owns 5,500,000 shares of Issuer
common stock or 8.5% of the outstanding shares.
(b) Power to Vote and Dispose
Dr. Tuch has sole power to vote, or to direct the voting of, and
the sole power to dispose or to direct the disposition of the
5,000,000 shares of the Issuer common stock owned directly by
Richard Tuch, M.D., A Professional Corporation Profit Sharing Plan
(401K).
(c) Transactions within the Past 60 Days
The following lots of shares has been purchased in the last 60
days:
DATE #SHARES PURCHASED PURCHASE PRICE/SHARE BROKERAGE
ACCT.
1a.6/30/2011 500,000 .0065 Merril Lynch
1b. 6/21/11 400,000 shares .0085 Charles Schwab
2. 6/19/11 350,000 shares .0135 Merrill Lynch
3. 6/14/11 850,000 shares .0054 Merrill Lynch
------------------------------------------------------------------------------
-------------------------------------------------
3. 6/20/11 50,000 shares .0095 Charles Schwab
4. 6/17/11 49,900 shares .0148 Charles Schwab
5. 6/16/11 30,000 shares .0155 Charles Schwab
35,712 shares .0155 Charles Schwab
100 shares .018 Charles Schwab
34,288 shares .018 Charles Schwab
6. 6/14/11 500,000 shares .0028 Charles Schwab
7. 6/3/11 300,000 shares .0022 Charles Schwab
------------------------------------------------------------------------------
-------------------------------------------------
8. 5/10/11 50,000 shares .004 Charles Schwab
100,000 .0045 Charles Schwab
9. 5/4/11 150,000 .0055 Charles Schwab
100,000 .005 Charles Schwab
------------------------------------------------------------------------------
-------------------------------------------------
TOTAL 3,500,000
(d) Certain Rights of Other Persons
Not applicable.
(e) Not applicable.
ITEM 6. CONTRACT, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Not applicable
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Not applicable
SCHEDULE 13D
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct.
July 7, 2011
------------------------------------
----------------------------
(Date)
Richard Tuch, M.D. A Professional
Corporation Profit Sharing Plan
(401K)
By: /s/ Richard Tuch
------------------------------------
----------------------------
Richard Tuch, President
------------------------------------
----------------------------
Name and Title
